Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now São Paulo - Delayed Quote • BRL Novo Nordisk A/S (N1VO34.SA) Follow Add holdings 44.27 +0.76 +(1.75%) As of 2:11:19 PM GMT-3. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for N1VO34.SA 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: N1VO34.SA View More All News Press Releases SEC Filings Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock? Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock? Is Eli Lilly Stock a Buy? Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill Novo Nordisk (NVO) Is a Good Short-Term Pick, Wealth Manager Says Why Novo Nordisk Stock Popped Today Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time. Trending tickers: Nvidia, Tesla, Roche, Novo Nordisk and Fresnillo Novo shares down on Eli Lilly’s positive obesity pill data Novo Nordisk Drops on Weight-Loss Study by Rival Lilly